Singapore's leading specialty pharmaceutical and consumer healthcare group, is pleased to announce that it has granted the rights to commercialise its innovative product, Cerapro® MED Skin Barrier ...

The latest update is out from Hyphens Pharma International Ltd. ( ($SG:1J5) ). Hyphens Pharma International has entered into a licensing, supply ...

WINNIPEG - HUMN Pharmaceuticals announced today that they have now distributed their flagship pain relief product to over one million satisfied customers in North America. The unique formulation of ...

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.

MUMBAI, Aug. 30, 2019 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Pimecrolimus Cream, 1 ...

BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc ("Cosette"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary ...

Innovus Pharmaceuticals to Acquire Ex-U.S. Rights to the Marketed Skin Cream CIRCUMserum(TM), for Enhancement of Sexual Sensation in Men LA JOLLA, Calif., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Innovus ...

DUBLIN and MUMBAI, India, Dec. 1, 2025 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), announced that the European Commission (EC) has ...

Cerapro is a patented, skin pH-lowering cream approved for the treatment of atopic dermatitis under the European Medical Device Regulation (CE Mark)Product launch targeted for 2026 in six European ...